Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Modulation of the Immune System in Down Syndrome for Improved Outcomes and Neurodevelopment - 1

NCT07598643 is registered in ClinicalTrials.gov with University of Colorado, Denver as lead sponsor.

NCT NCT07598643
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07598643 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Modulation of the Immune System in Down Syndrome for Improved Outcomes and Neurodevelopment - 1
Lead sponsor
University of Colorado, Denver
Phase
Phase 2
Overall status
Recruiting
Start date
May 28, 2026
Completion date
August 31, 2030
Enrollment
92 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

down syndrome